Updates are available Correction dated 2021-05-25
Click to view Correction: https://doi.org/10.1038/s41564-021-00923-x
-
Authors
Wang, Ya-Ting https://orcid.org/0000-0002-5057-4083
Zaitsev, Konstantin https://orcid.org/0000-0003-3749-0886
Lu, Qun
Li, Shan
Schaiff, W. Timothy
Kim, Ki-Wook
Droit, Lindsay
Wilen, Craig B. https://orcid.org/0000-0003-2495-9403
Desai, Chandni
Balce, Dale R.
Orchard, Robert C. https://orcid.org/0000-0001-8216-4946
Orvedahl, Anthony
Park, Sunmin
Kreamalmeyer, Darren
Handley, Scott A.
Pfeifer, John D.
Baldridge, Megan T. https://orcid.org/0000-0002-7030-6131
Artyomov, Maxim N.
Stallings, Christina L. https://orcid.org/0000-0002-2747-5618
Virgin, Herbert W. https://orcid.org/0000-0001-8580-7628
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (K08 A128043)
Foundation for the National Institutes of Health (U19 AI42784)
Foundation for the National Institutes of Health (R01 AI132697)
Foundation for the National Institutes of Health (U19 AI109725)
Pediatric Infectious Diseases Society
Burroughs Wellcome Fund
Crohn’s and Colitis Foundation (326556)
- License Information
-
More Information
Article History
Received: 23 January 2019
Accepted: 5 November 2019
First Online: 20 January 2020
Change Date: 25 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41564-021-00923-x
Competing interests
: H.W.V. is a founder of Casma Therapeutics and PierianDx. The work reported here was not funded by either company.
